SAN DIEGO, Sept. 9, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Dr. Bassam Damaj, Chairman, President and Chief Executive Officer, will present an overview of its wholly-owned subsidiary, NexMed (USA), Inc.'s Rx and Consumer Healthcare Divisions, at the 11th Annual Biotech in Europe Investor Forum on September 14, 2011 at 12:15 pm CEST, at the Hilton Zurich Airport Hotel in Zurich, Switzerland.
